Century Sunshine Group Holdings Past Earnings Performance
Past criteria checks 0/6
Century Sunshine Group Holdings's earnings have been declining at an average annual rate of -42.7%, while the Chemicals industry saw earnings growing at 7.4% annually. Revenues have been declining at an average rate of 49% per year.
Key information
-42.7%
Earnings growth rate
-42.7%
EPS growth rate
| Chemicals Industry Growth | 10.2% |
| Revenue growth rate | -49.0% |
| Return on equity | -75.4% |
| Net Margin | -75.0% |
| Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
There's Reason For Concern Over Century Sunshine Group Holdings Limited's (HKG:509) Price
Jun 04
Century Sunshine Group Holdings Limited's (HKG:509) Price Is Out Of Tune With Revenues
Feb 19Is Century Sunshine Group Holdings (HKG:509) Weighed On By Its Debt Load?
Oct 27Calculating The Fair Value Of Century Sunshine Group Holdings Limited (HKG:509)
Aug 12Revenue & Expenses Breakdown
How Century Sunshine Group Holdings makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 316 | -237 | 281 | 0 |
| 30 Sep 23 | 315 | -547 | 265 | 0 |
| 30 Jun 23 | 314 | -858 | 361 | 0 |
| 31 Mar 23 | 423 | -933 | 500 | 0 |
| 31 Dec 22 | 532 | -1,007 | 528 | 0 |
| 30 Sep 22 | 693 | -1,185 | 609 | 0 |
| 30 Jun 22 | 855 | -1,362 | 690 | 0 |
| 31 Mar 22 | 1,093 | -1,242 | 552 | 0 |
| 31 Dec 21 | 1,332 | -1,122 | 413 | 0 |
| 30 Sep 21 | 1,597 | -997 | 421 | 0 |
| 30 Jun 21 | 1,862 | -872 | 428 | 0 |
| 31 Mar 21 | 2,007 | -809 | 434 | 0 |
| 31 Dec 20 | 2,152 | -745 | 440 | 0 |
| 30 Sep 20 | 2,729 | -293 | 422 | 0 |
| 30 Jun 20 | 3,306 | 159 | 403 | 0 |
| 31 Mar 20 | 3,810 | 270 | 405 | 0 |
| 31 Dec 19 | 4,314 | 380 | 406 | 0 |
| 30 Jun 19 | 4,562 | 483 | 350 | 0 |
| 31 Mar 19 | 4,609 | 467 | 358 | 0 |
| 31 Dec 18 | 4,655 | 452 | 367 | 0 |
| 30 Jun 18 | 4,272 | 322 | 437 | 0 |
| 31 Mar 18 | 3,857 | 289 | 404 | 0 |
| 31 Dec 17 | 3,443 | 257 | 372 | 0 |
| 30 Sep 17 | 3,088 | 280 | 309 | 0 |
| 30 Jun 17 | 2,732 | 303 | 246 | 0 |
| 31 Mar 17 | 2,661 | 303 | 250 | 0 |
| 31 Dec 16 | 2,589 | 302 | 253 | 0 |
| 30 Sep 16 | 2,568 | 276 | 252 | 0 |
| 30 Jun 16 | 2,548 | 249 | 250 | 0 |
| 31 Mar 16 | 2,532 | 282 | 251 | 0 |
| 31 Dec 15 | 2,516 | 314 | 251 | 0 |
| 30 Sep 15 | 2,435 | 329 | 220 | 0 |
| 30 Jun 15 | 2,355 | 344 | 189 | 0 |
| 31 Mar 15 | 2,214 | 316 | 178 | 0 |
| 31 Dec 14 | 2,073 | 288 | 166 | 0 |
| 30 Sep 14 | 1,960 | 279 | 163 | 0 |
| 30 Jun 14 | 1,848 | 270 | 160 | 0 |
| 31 Mar 14 | 1,744 | 250 | 142 | 0 |
| 31 Dec 13 | 1,640 | 230 | 125 | 0 |
Quality Earnings: 509 is currently unprofitable.
Growing Profit Margin: 509 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 509 is unprofitable, and losses have increased over the past 5 years at a rate of 42.7% per year.
Accelerating Growth: Unable to compare 509's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 509 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-18.6%).
Return on Equity
High ROE: 509 has a negative Return on Equity (-75.4%), as it is currently unprofitable.